Honda Begins Joint Demonstration of Stationary Fuel Cell Power Station Designed to Utilize By-product Hydrogen and Repurposed Automotive Fuel Cells

TOKYO, Japan, August 1, 2025 - (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. (Honda) has started a demonstration project jointly with Tokuyama Corporation (Tokuyama) and Mitsubishi Corporation (MC), to operate a data center using by-product hydrogen and a stationary fuel cell (FC) power station designed to reuse FC…

Isuzu’s first battery-electric pickup “D-MAX EV” adopts eAxle

KARIYA, JAPAN, August 1, 2025 - (JCN Newswire via SeaPRwire.com) - BluE Nexus Corporation (headquartered in Anjo, Aichi; Hidetoshi Uchiyama, president; hereinafter “BluE”), AISIN Corporation (headquartered in Kariya, Aichi; Moritaka Yoshida, president; hereinafter “AISIN”), and DENSO CORPORATION (headquartered in Kariya, Aichi; Shinnosuke Hayashi, president; hereinafter “DENSO”) are proud to announce that,…

Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030

Kawasaki, Japan, August 1, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced that it has started research and development towards a superconducting quantum computer with a capacity exceeding 10,000 qubits. Construction is slated for completion in fiscal 2030.The new superconducting quantum computer will operate with 250 logical qubits and…

Revenue of LEQEMBI(R) (Preliminary Basis)

TOKYO, July 31, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that the global revenue(pre-audit basis) of the anti-amyloid-beta protofibril antibody “LEQEMBI®” (generic name: lecanemab) was JPY 23.1 billion for the first quarter of fiscal year 2025 (April 1, 2025 –…

TANAKA PRECIOUS METAL GROUP Announces Business Partnership with JEPLAN to Realize a Decarbonized, Circular Society

TOKYO, July 31, 2025 - (JCN Newswire via SeaPRwire.com) - TANAKA PRECIOUS METAL GROUP Co., Ltd. (Headquarters: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka) has decided to enter into a business partnership with JEPLAN, INC. (Headquarters: Kawasaki City, Kanagawa; Representative Director, President, and Chief Executive Officer: Masaki Takao; hereinafter “JEPLAN”) to reduce…

Collaborative Development of Ultra-Compact and Lightweight Satellite Communication User Terminals for Mobility with Mitsubishi Chemical, NICT, and TECHLAB

TOKYO, July 30, 2025 - (JCN Newswire via SeaPRwire.com) - Sharp Corporation has reached an agreement with Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Manabu Tsukimoto), the National Institute of Information and Communications Technology (NICT) (Headquarters: Koganei City, Tokyo; President: Hideyuki Tokuda), and TECHLAB Co., Ltd. (Headquarters: Tama City, Tokyo;…

Mitsubishi Heavy Industries Concludes Agreement with Modius to Provide DCIM Solutions for Data Centers Worldwide

Mitsubishi Heavy Industries aims to integrate DCIM (Data Center Infrastructure Management) into its One-stop solutions portfolio to offer digital services to data centersThe combination delivers a comprehensive view of data center infrastructure, enabling enhanced visibility, elevated operational efficiency and optimized energy consumptionTOKYO, July 29, 2025 - (JCN Newswire via SeaPRwire.com)…

LENVIMA(R) (lenvatinib) in Combination with Pembrolizumab and Transarterial Chemoembolization (TACE) Approved in China for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma

TOKYO, July 29, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic name: lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial chemoembolization (TACE) has been approved by the National…

Prototype divertor outer vertical target for the ITER fusion experimental reactor is completed and the sample has passed the ITER Organization’s certification test

- Rationalization of domestic production technologies and strengthening of the system in Japan for manufacturing divertor outer vertical targets for ITER- Seeking to contribute to the ITER Project and provide components for the prototype reactor for fusion energy and startup machinesTOKYO, July 23, 2025 - (JCN Newswire via SeaPRwire.com) -…

Launch of Beova(R) Tablets in Thailand for Overactive Bladder

TOKYO, July 23, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yutaka Ogihara, “KYORIN”) announced today that Eisai (Thailand) Marketing Co., Ltd. (“Eisai Thailand”), a subsidiary of Eisai, has launched overactive bladder treatment…

Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support

SAN DIEGO, July 23, 2025 - (JCN Newswire via SeaPRwire.com) - Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, announced today that its San Diego laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This significant…

Mitsubishi Motors to Terminate Its Joint Venture Partnership with Shenyang Aerospace Mitsubishi Motors Engine Manufacturing

TOKYO, July 22, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the termination of its engine business operation at Shenyang Aerospace Mitsubishi Motors Engine Manufacturing Co., Ltd. (hereinafter, SAME) in China and has terminated the joint venture partnership.Established in August 1997, SAME began engine…